Stockreport

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Nautilus Biotechnology, Inc.  (NAUT) 
PDF SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, [Read more]